INTRODUCTION
Acetyl salicylic acid (ASA; aspirin)-intolerant asthma (AIA) is a distinct clinical condition characterized by the 'aspirin triad' syndrome of aspirin hypersensitivity, eosinophilic rhinosinusitis, nasal polyposis, and bronchial asthma, and is known to affect 10-20% of adult asthmatic patients (1) (2) (3) (4) (5) (6) (7) . AIA is due to the development of bronchoconstriction in asthma patients following ingestion of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs). Although the underlying mechanisms of AIA have not been elucidated completely, arachidonic acid metabolites such as prostaglandins (PGs), leukotrienes (LTs), and thromboxane (TBX) are reportedly involved in the pathogenesis of this asthma phenotype (8) (9) (10) . Anti-inflammatory PGs are one of the various types of oxygenated metabolites generated by the cyclooxygenase (COX) pathway that function to reduce the level of PGE2, the main COX2 metabolite (11) (12) (13) . The cyclooxygenase theory is widely accepted as responsible for the pathogenesis of AIA. Inhibition of COXs by NSAIDs in the respiratory tract alters arachidonic acid metabolism, leading to reduction of PGE2 and alteration of AIA pathogenesis (9-11, 14, 15) . Therefore, the overproduction or underproduction of critical mediators of arachidonic acid metabolism, such as PGs, probably accounts for disease susceptibility (2) .
Prostaglandin E2 (PGE2), an arachidonic acid metabolite, is a key factor in the generation of abnormal pain sensations incited by inflammation (16) . PGE2 is synthesized and secreted by diverse cell types and plays an important role in balancing the Th1/Th2 immune responses (17, 18) . PGE2 exerts its biological effects by binding to four different G protein-coupled receptors encoded by the following separate genes: PTGER1 (MIM# 176802), PTGER2 (MIM# 176804), PTGER3 (MIM# 176806), and PTGER4 (MIM# 601586). These four receptors shows different tissue distribution and physiological functions and work in different signaling pathways (19) (20) (21) . The role of PGE2 in the pathogenesis of AIA was investigated by focusing on reduced PGE2 release caused by aspirin-induced cyclooxygenase inhibition (11, 14, 22) .
Although a recent study suggested that the role of PGE2 in http://bmbreports.org the pathogenesis of asthma is independent of aspirin intolerance (23) , others have shown that genetic variations in PGE2 receptors are strongly associated with AIA pathogenesis (24, 25) . Therefore, to replicate the effects of these genetic variations, we genotyped 120 polymorphisms of the PTGER gene family in a large case-control study of a Korean population and assessed their risk of AIA (n=1,162).
RESULTS AND DISCUSSION
In the present study, a total of 1,162 subjects were recruited for the asthma cohort, the clinical characteristics of which are summarized in Table 1 . Significant differences in mean age, prevalence of smoking, and body mass index (BMI) were found between the AIA and the ATA groups (P ＜ 0.05). Forced vital capacity in the first second (FVC1), forced expiratory volume in the first second (FEV1), and log [20% fall in FEV1 (PC20)] were significantly different between AIA and ATA groups in the 2 nd study. The mean aspirin-induced decline in FEV1 was lower in the 2 nd study than in the 1 st study due to a larger number of AIA-intermediate subjects in the 2 nd study (34.3% of AIA-intermediates in 1 st study and 54.7% in 2 nd study). Furthermore, an aspirin-induced decline in FEV1 from -15% to 82% was observed among the subjects.
For the 1 st study, we scrutinized candidate gene variants in four PTGER genes from databases of NCBI dbSNP (build 36). One hundred and twenty variants, including 2 SNPs in PTGER1, 12 in PTGER2, 103 in PTGER3, and 3 in PTGER4, were successfully genotyped using the Illumina Golden Gate genotyping system in 137 AIA and 268 ATA subjects of Korean ethnicity. The overall call rate for all SNPs was 99.80%. The minor allele frequencies (MAFs) of these 120 SNPs in each AIA and ATA group are summarized in supplementary Table  1 . The distributions of all loci were in Hardy-Weinberg equilibrium (P ＞ 0.01) except rs11209710 and rs7543182 (P = 0.005 and 0.007, respectively). Haplotypes of the four PTGER receptor genes were constructed, and PTGER3 was parsed into three haplotype blocks with each block having a strong LD spine (Data not shown). There were three common haplotypes in PTGER1, six in PTGER2, five in block 1 of PTGER3, three in block 2 of PTGER3, five in block 3 of PTGER3, and three in PTGER4. Multiple logistic regression models found that two SNPs and two haplotypes of PTGER1 along with ten SNPs of PTGER3 were marginally associated with intolerance to AIA, whereas six SNPs of PTGER3 along with a haplotype of PTGER2 showed marginal association with increased risk of AIA (Supplementary Table 2 ). Among the positively associated SNPs, one in PTGER1 (rs2241363) and four in PTGER3 (rs6424414, rs516647, rs7543182 and rs959) were selected due to their LD status for a 2 nd replication study of 106 AIA and 651 ATA subjects. Statistical analysis revealed that rs7543182 and rs959 in PTGER3 retained their effects in the 2 nd cohort. That is, these two polymorphisms retained their susceptibility to aspirin intolerance, although there was no longer any statistical significance (Table 2) . However, rs2241363 in PTGER1 along with rs6424414 and rs516647 in PTGER3 failed to replicate its effect and statistical significance in the 2 nd cohort. A recent study using PTGER3-knockout mice showed that the relationship between PGE2 and asthma is unrelated to aspirin intolerance (23), whereas genetic variations in PGE2 receptors may be an important genetic factor in the pathogenesis of AIA in Japanese individuals (25) . In the Korean population, polymorphisms in the PTGER2, PTGER3, and PTGER4 genes http://bmbreports.org BMB reports The P values were obtained by logistic regression analysis, controlled for age (continuous value), sex (male = 0, female = 1), atopy status (non-atopy = 0, atopy = 1), BMI and smoking status (non-smoker = 0, ex-smoker = 1, smoker = 2) as co-variables are known to be associated with aspirin intolerance, whereas polymorphisms in PTGER1 have not yet been reported to affect aspirin intolerance among asthmatics (24) . Previous studies have shown that polymorphisms in PTGER1 are unrelated with asthma and aspirin intolerance, although the inhibition of PTGER1-mediated signaling plays an important role in the effect of NSAIDs in pain reduction in an acetic acid model (24, 26, 27) . However, the current study showed that PTGER1 rs2241363 exhibited a protective effect with regards to AIA. To our knowledge, this is the first study demonstrating the importance of genetic variations in PTGER1 to ones predisposition to aspirin intolerance. PTGER3 is known to enhance the inflammatory response through coupling with PGE2. It is also involved in the suppression of allergic inflammation in an animal model of asthma (23) . It has been reported that PTGER3 polymorphisms are important genetic factors affecting the risk and severity of asthma as well as the pathogenesis of AIA (24, 26) . Among two associated polymorphisms in PTGER3, rs959 on the 3'UTR region was significantly associated with an increased risk of AIA in codominant and dominant models (P = 0.005 and 0.002, respectively). Although the mechanism of AIA associated with alternative genotypes in the 3' UTR is not totally understood, there are several possible explanations based on the role of the noncoding portion of the genome. It is known that mRNA UTRs are involved in many post-transcriptional regulatory pathways that control mRNA localization, stability, and translation efficiency. Moreover, the initiation of protein synthesis could be influenced by sequence elements in both the 5' and 3' UTRs. Therefore, post-transcriptional events play important yet not fully understood roles in the regulation of gene expression and cellular behavior. In fact, many of the cis-acting elements that affect translational regulation are located within the 3' UTR (28) .
In summary, we examined the genetic association of four PGE2 receptors, including PTGER1, PTGER2, PTGER3, and PTGER4, with aspirin intolerance among Korean asthmatics (n=1,162). Although all signals were not retained after correction, our study suggests that polymorphisms in PTGER3 might be important genetic factors in controlling aspirin intolerance among Korean asthmatics. Therefore, further biological and/or functional evidence is needed to confirm the associations in this study.
MATERIALS AND METHODS

Subjects
The subjects, all of whom were Korean, were recruited from the Asthma Genome Research Center, which is comprised of nine university hospitals in Korea. All patients were diagnosed by a physician and met the definition of asthma as set forth in the Global Initiative for Asthma (GINA) guidelines. All patients had a history of dyspnea and wheezing over the previous 12 months plus one of the following: 1) ＞15% increase in FEV1 http://bmbreports.org or ＞12% increase plus 200 ml following inhalation of a short-acting bronchodilator, 2) ＜10 mg/ml PC20 methacholine, and 3) ＞20% increase in FEV1 following 2 weeks of treatment with inhaled steroids and long-acting bronchodilators. Twenty-four common inhalant allergens were used for a skin prick test (29) . Total IgE was measured by the CAP system (Pharmacia Diagnostics, Uppsala, Sweden). Atopy was defined as having a wheal reaction equal to or greater than histamine or 3 mm in diameter. The asthmatic patients experienced no worsening of asthma and or tract infection during the 6 weeks preceding oral aspirin challenge (OAC). OAC was performed with increasing doses of aspirin using slightly modified methods (29, 30) . Changes in FEV1 were followed for 5 hours after the last aspirin challenge. Aspirin-induced bronchospasms, as reflected by rate (%) of FEV1 decline, were calculated as the pre-challenge FEV1 minus the post-challenge FEV1 divided by the pre-challenge FEV1. OAC reactions were categorized into 3 groups as follows: 20% or greater decrease in FEV1 or 15% to 19% decrease in FEV1 with naso-ocular or cutaneous reactions (aspirin intolerant asthma: AIA), 15% to 19% decrease in FEV1 or naso-ocular or cutaneous reactions only (intermediate AIA: AIA-I), and 15% or less decrease in FEV1 without naso-ocular or cutaneous reactions (aspirin tolerant asthma: ATA).
Peripheral venous blood was collected, and plasma was separated before and at the time of bronchospasm, or 2 hr after aspirin challenge. Peripheral blood mononuclear cells (PBMC) were separated in a Histopaque-1077 solution (1.077 g/ml, Sigma, St. Louis, MO). All subjects gave informed, written consent for participation in the study. The protocols were approved by the local ethics committees of each hospital.
SNP selection and genotyping
We selected polymorphic candidate SNPs for the 1 st study from the National Center for Biotechnology Information (build 36), and then genotyped 137 AIA and 268 ATA subjects. For the 2 nd study, additional subjects (106 AIA and 651 ATA) were employed. One SNP in PTGER1 and four in PTGER3 showing putative positive association in the 1 st study were selected and genotyped. Genotyping in the 1 st study was performed at the multiplex level using the Illumina Golden Gate genotyping system (31) , and data quality was assessed by duplicate DNAs (n = 10). The genotype quality score for retaining data was set to 0.25. SNPs that could not satisfy the following criteria were excluded from the study: (i) a minimum call rate of 90%; (ii) no duplication error; (iii) Hardy-Weinberg equilibrium greater than P ＞ 0.001. A total of 120 SNPs, including 2 SNPs in PTGER1, 12 SNPs in PTGER2, 103 SNPs in PTGER3, and 3 SNPs in PTGER4, were successfully genotyped. Genotyping probe information is presented in supplementary Table 3 . Genotyping in the 2 nd study was performed using TaqMan Ⓡ (32) assay. Primer Express (Applied Biosystems) was used to design both the PCR primers and MGB TaqMan probes. One allelic probe was labeled with FAM dye while the other with fluorescent VIC dye. Genotyping probe information is presented in supplementary Table 4 .
Statistics
We applied common measures of linkage disequilibrium to all pairs of biallelic loci: Lewontin's D' (|D'|) (33) and r 2 . Haplotypes of each individual were inferred using PHASE algorithm (ver. 2.0) developed by Stephens et al. (34) The genotype and haplotype distribution were analyzed using logistic regression models using age (continuous value), gender (male = 0, female = 1), smoking status (non-smoker = 0, ex-smoker = 1, smoker = 2), atopy (absence = 0, presence = 1), and BMI as covariates. Differences in the rates of FEV1 decline following aspirin challenge among the genotypes and haplotypes were examined using a linear regression model. The data were managed and analyzed using SAS version 9.1 (SAS Inc., Cary, NC).
